TrivarX Past Earnings Performance
Past criteria checks 0/6
TrivarX's earnings have been declining at an average annual rate of -2.4%, while the Healthcare Services industry saw earnings growing at 12.3% annually. Revenues have been declining at an average rate of 30.7% per year.
Key information
-2.4%
Earnings growth rate
58.5%
EPS growth rate
| Healthcare Services Industry Growth | 42.6% |
| Revenue growth rate | -30.7% |
| Return on equity | -14.5% |
| Net Margin | -161.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How TrivarX makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -1 | 1 | 0 |
| 31 Mar 24 | 0 | -3 | 1 | 0 |
| 31 Dec 23 | 0 | -4 | 1 | 0 |
| 30 Sep 23 | 0 | -3 | 1 | 0 |
| 30 Jun 23 | 1 | -3 | 1 | 0 |
| 31 Mar 23 | 1 | -8 | 1 | 1 |
| 31 Dec 22 | 1 | -12 | 1 | 1 |
| 30 Sep 22 | 1 | -13 | 1 | 1 |
| 30 Jun 22 | 1 | -13 | 1 | 1 |
| 31 Mar 22 | 1 | -7 | 1 | 1 |
| 31 Dec 21 | 1 | -1 | 1 | 0 |
| 30 Sep 21 | 1 | -1 | 1 | 0 |
| 30 Jun 21 | 1 | -1 | 1 | 0 |
| 31 Mar 21 | 1 | -2 | 1 | 0 |
| 31 Dec 20 | 1 | -2 | 1 | 0 |
| 30 Sep 20 | 1 | -3 | 1 | 0 |
| 30 Jun 20 | 1 | -4 | 2 | 0 |
| 31 Mar 20 | 1 | -4 | 2 | 0 |
| 31 Dec 19 | 1 | -5 | 2 | 1 |
| 30 Sep 19 | 3 | -6 | 3 | 1 |
| 30 Jun 19 | 4 | -7 | 5 | 0 |
| 31 Mar 19 | 3 | -11 | 6 | 1 |
| 31 Dec 18 | 3 | -15 | 8 | 2 |
| 30 Sep 18 | 3 | -15 | 7 | 3 |
| 30 Jun 18 | 2 | -16 | 7 | 3 |
| 31 Mar 18 | 3 | -15 | 5 | 5 |
| 31 Dec 17 | 3 | -13 | 4 | 6 |
| 30 Sep 17 | 3 | -11 | 3 | 5 |
| 30 Jun 17 | 3 | -10 | 2 | 4 |
| 31 Mar 17 | 3 | -9 | 2 | 3 |
| 31 Dec 16 | 4 | -7 | 1 | 2 |
| 30 Sep 16 | 3 | -7 | 1 | 2 |
| 30 Jun 16 | 2 | -6 | 1 | 2 |
| 31 Mar 16 | 2 | -6 | 1 | 1 |
| 31 Dec 15 | 1 | -7 | 0 | 0 |
| 30 Sep 15 | 1 | -7 | 0 | 0 |
| 30 Jun 15 | 0 | -8 | 0 | 0 |
| 31 Mar 15 | 0 | -5 | 0 | 0 |
| 31 Dec 14 | 0 | -2 | 0 | 0 |
| 30 Sep 14 | 0 | -1 | 0 | 0 |
| 30 Jun 14 | 0 | 0 | 0 | 0 |
| 31 Mar 14 | 0 | 0 | 0 | 0 |
| 31 Dec 13 | 0 | 0 | 0 | 0 |
Quality Earnings: TRI is currently unprofitable.
Growing Profit Margin: TRI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TRI is unprofitable, and losses have increased over the past 5 years at a rate of 2.4% per year.
Accelerating Growth: Unable to compare TRI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TRI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (21.3%).
Return on Equity
High ROE: TRI has a negative Return on Equity (-14.5%), as it is currently unprofitable.